(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.31%) $78.72
(-1.23%) $2.17
(-0.03%) $2 330.50
(0.00%) $27.61
(0.80%) $972.65
(0.05%) $0.929
(0.15%) $10.84
(0.05%) $0.796
(-0.01%) $91.34
0.00% $ 17.14
@ $17.66
Wydano: 14 vas. 2024 @ 21:01
Zwrot: -2.94%
Poprzedni sygnał: vas. 13 - 22:45
Poprzedni sygnał:
Zwrot: 3.03 %
Live Chart Being Loaded With Signals
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 597 116 |
Średni wolumen | 1.27M |
Kapitalizacja rynkowa | 2.44B |
EPS | $0 ( 2024-02-26 ) |
Następna data zysków | ( $-0.670 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -16.17 |
ATR14 | $0.0150 (0.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Sato Vicki L | Sell | 1 666 | Common Stock |
2024-04-01 | Krognes Steve E. | Sell | 92 500 | Common Stock |
2024-03-29 | Watts Ryan J. | Sell | 40 000 | Common Stock |
2024-03-15 | Sato Vicki L | Sell | 1 666 | Common Stock |
2024-02-15 | Sato Vicki L | Sell | 1 666 | Common Stock |
INSIDER POWER |
---|
33.15 |
Last 100 transactions |
Buy: 1 164 016 | Sell: 631 404 |
Wolumen Korelacja
Denali Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
RUBY | 0.908 |
ACRS | 0.907 |
HAS | 0.906 |
TUEM | 0.902 |
SBRA | 0.901 |
ALHC | 0.901 |
SIVBP | 0.897 |
MQ | 0.897 |
XP | 0.896 |
CCSI | 0.896 |
10 Najbardziej negatywne korelacje | |
---|---|
MBIN | -0.912 |
SCR | -0.902 |
KTCC | -0.901 |
MPWR | -0.897 |
ZIONP | -0.891 |
HUGE | -0.889 |
WIRE | -0.889 |
ITI | -0.888 |
PAE | -0.888 |
ICPT | -0.888 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Denali Therapeutics Inc Korelacja - Waluta/Towar
Denali Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $330.53M |
Zysk brutto: | $313.81M (94.94 %) |
EPS: | $-1.060 |
FY | 2023 |
Przychody: | $330.53M |
Zysk brutto: | $313.81M (94.94 %) |
EPS: | $-1.060 |
FY | 2022 |
Przychody: | $108.46M |
Zysk brutto: | $101.43M (93.52 %) |
EPS: | $-2.60 |
FY | 2021 |
Przychody: | $48.66M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.40 |
Financial Reports:
No articles found.
Denali Therapeutics Inc
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease. The company also develops DNL310 that is in Phase I/II clinical trials for the treatment of hunter syndrome; DNL343, which is in phase 1 clinical trial the treatment of amyotrophic lateral sclerosis (ALS); AR443820/DNL788 completed a phase I clinical trial for the treatment of ALS, multiple sclerosis (MS), and Alzheimer's disease; and SAR443122/DNL758, which is in phase II clinical trial for the treatment of cutaneous lupus erythematosus. It has collaboration agreement with Takeda Pharmaceutical Company, Genentech, Inc., Sanofi, F-star Gamma Limited, F-star Biotechnologische Forschungs-Und Entwicklungsges M.B.H, F-star Biotechnology Limited, SIRION Biotech GmbH, Genzyme Corporation, Harvard University, the Michael J. Fox Foundation, and Centogene; and a research and option agreement with Secarna Pharmaceuticals GmbH & Co. KG. to develop antisense therapies in the field of neurodegenerative diseases. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej